MFA-370

N/A

Report date: 2026/03/06 20:02:51

Base Information

Drug NameMFA-370
Drug Alias NameMFA-370
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate-gated chloride channel modulatorsCyclooxygenases inhibitors
TargetsGlutamate-gated chloride channelCyclooxygenases
Therapy Area/IndicationsCarcinoma, Transitional Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsYes IvermectinCarprofen
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEctin Research AB
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEctin Research AB
Active IndicationsN/A
Inactive IndicationsCarcinoma, Transitional Cell

Other Information

ATC CodeN/A
Related LinksN/A